Compare FMC Corp (FMC) vs Synopsys, Inc. (SNPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Synopsys, Inc. — how do they compare? FMC Corp trades at $11.4 (market cap $1.36B), while Synopsys, Inc. trades at $417.02 (market cap $81.43B). The key difference: Synopsys, Inc. is far larger — about 59.9× FMC Corp's market cap, and FMC Corp pays a 2.95% dividend while Synopsys, Inc. pays none. Which is the better fit depends on your goals.
| FMC | SNPS | |
|---|---|---|
Market Cap | $1.36B | $81.43B |
Sector | Basic Materials | Technology |
52-Week High | $43.90 | $645.59 |
52-Week Low | $10.72 | $380.47 |
Enterprise Value | $5.50B | $89.79B |
Dividend Yield | 2.95% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.
The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.
Synopsys (SNPS) trades at $423.37, down 0.57% on the day, with a bearish technical signal driven by moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS expected at $3.68. Recent news highlights the company's strategic pivot toward AI-driven design tools and its role in the semiconductor ecosystem. Valuation ratios remain elevated, with a P/E of 97.32 and P/S of 8.98, reflecting high growth expectations.
The outlook for SNPS is supported by strong analyst sentiment, with 82.76% buy ratings and a consensus price target of $559.50, implying significant upside. However, risks include competitive pressures, execution challenges in integrating Ansys, and macroeconomic volatility affecting semiconductor demand. The stock's high valuation requires sustained earnings growth to justify current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Synopsys, Inc.
Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →
